News

  • ASCOT removes aspirin from trial

    On the 22 July 2021, the ASCOT International Trial Steering Committee (ITSC) made the decision to cease patient enrolment into aspirin-containing a...
  • Oxford is trialling Ivermectin - the path to this point has been rocky, why?

    By Associate Professor Justin Denholm, Principal Investigator on ASCOT The PRINCIPLE trial recently announced that their ongoing platform will now ...
  • COVID-19 – The Israel experience

    By Dr Neta Petersiel, Clinical Research Fellow for ASCOT  The past 18 months often feel like a weird dream, our reality perhaps forever changed by ...
  • National approach to pandemic research needed

    Australia should follow the examples of the UK and parts of the US and establish a national, coordinated approach for randomised controlled trials...
  • Infection and Immunity – Evidence Explained podcast: COVID-19 treatments part one, the Australian experience

    In the latest episode of Doherty Institute's Infection and Immunity - Evidence Explained podcast, Associate Professor Steven Tong, Infectious Disea...
  • Nafamostat for treatment of COVID-19

    As COVID-19 is a new disease resulting in an unprecedented global healthcare burden, there have been a very large number of drugs rapidly escalated...
  • AustralaSian COVID-19 Trial opens in India

    The AustralaSian COVID-19 Trial (ASCOT) has been expanded into India, with the first patients recruited last week to the first two sites, Christi...
  • ASCOT removes convalescent plasma from trial

    The ASCOT International Trial Steering Committee (ITSC) has made the decision to cease enrolment into the convalescent plasma arm of the trial. A ...
  • The case for including pregnant women in COVID-19 clinical trials

    Written by Dr Megan Rees, Chief Investigator, AustralaSian COVID-19 Clinical Trial, Respiratory and Sleep Physician, Royal Melbourne Hospital on b...
  • Standard of care explained

    Written by Dr Megan Rees, Chief Investigator, AustralaSian COVID-19 Clinical Trial, Respiratory and Sleep Physician, Royal Melbourne Hospital and ...
  • It is scary enough being treated for COVID-19 – why would a patient also consider being part of a research trial?

    Written by Dr Megan Rees, Chief Investigator, AustralaSian COVID-19 Clinical Trial, Respiratory and Sleep Physician, Royal Melbourne Hospital and ...
  • Convalescent plasma for COVID-19

    Convalescent plasma is a treatment arm in ASCOT. Participants are randomised (like the flip of a coin) to either receiving convalescent plasma or the usual best standard of care without convalescent plasma.